SMTL ID : 4zji.3 (3 other biounits)

PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x 4OQ: 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine(Non-covalent)

4OQ.1: 17 residues within 4Å: Chain A: E.69, V.72, M.73, N.76, I.81, V.82, Y.84, F.133, L.134, N.137, V.139, H.141, L.159, T.160, D.161, A.166, Q.167 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.81, A:I.81, A:F.133, A:L.134, A:D.161 Salt bridges: A:E.69

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: E.210, E.215 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:E.215, H2O.1, H2O.1, H2O.3, H2O.4, H2O.5

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Karpov, A.S. et al., Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor. Acs Med.Chem.Lett. (2015)

Release Date

2015-06-24

Peptides

Serine/threonine-protein kinase PAK 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Serine/threonine-protein kinase PAK 1

Related Entries With Identical Sequence